Skin Rashes Research Today is a free monthly online journal that collates and summarizes the latest research about Skin Rashes, including details on dermatitis, itches, creams, medication, treatment.

Volume 2 (2005), Issue 7 (July)

1. Association of NOD1 polymorphisms with atopic eczema and related phenotypes.
   J Allergy Clin Immunol, 116(1): 177-84. [Abstract] [Full-text]
2. Advances in allergic skin disease, anaphylaxis, and hypersensitivity reactions to foods, drugs, and insects.
   J Allergy Clin Immunol, 116(1): 153-63. [Abstract] [Full-text]
3. The Canadian Childhood Asthma Primary Prevention Study: outcomes at 7 years of age.
   J Allergy Clin Immunol, 116(1): 49-55. [Abstract] [Full-text]
4. Primary prevention of asthma and allergy.
   J Allergy Clin Immunol, 116(1): 3-14; quiz 15. [Abstract] [Full-text]
5. Incidence of mucocutaneous reactions in children treated with niflumic acid, other nonsteroidal antiinflammatory drugs, or nonopioid analgesics.
   Pediatrics, 116(1): e26-33. [Abstract] [Full-text]
6. Treatment with oral bromelain decreases colonic inflammation in the IL-10-deficient murine model of inflammatory bowel disease.
   Clin Immunol, 116(2): 135-42. [Abstract] [Full-text]
7. Serum alpha- and gamma-tocopherol levels in atopic mothers and their infants are correlated.
   Biol Neonate, 88(1): 24-6. [Abstract] [Full-text]
8. Adjuvant low-dose cidofovir therapy for BK polyomavirus interstitial nephritis in renal transplant recipients.
   Am J Transplant, 5(8): 1997-2004. [Abstract] [Full-text]
9. Trichobilharzia regenti: the developmental differences in natural and abnormal hosts.
   Parasitol Int, 54(3): 167-72. [Abstract] [Full-text]
10. Restricted MHC-peptide repertoire predisposes to autoimmunity.
    J Exp Med, 202(1): 73-84. [Abstract] [Full-text]
11. Contact dermatitis to quinoline, corticosteroids and antibiotics after short time treatment of delayed wound healing following malignant melanoma excision in a young woman.
    Skin Res Technol, 11(3): 218-9. [Abstract] [Full-text]
12. Objective evaluation of the efficacy of daily topical applications of cosmetics bases using the hairless mouse model of atopic dermatitis.
    Skin Res Technol, 11(3): 209-17. [Abstract] [Full-text]
13. Comparative evaporimetry in man.
    Skin Res Technol, 11(3): 205-8. [Abstract] [Full-text]
14. Quantitative analysis of the 26 allergens for cosmetic labeling in fragrance raw materials and perfume oils.
    J Agric Food Chem, 53(14): 5487-91. [Abstract] [Full-text]
15. Phase I study of the combination of topotecan and irinotecan in children with refractory solid tumors.
    Cancer Chemother Pharmacol. [Abstract] [Full-text]
16. Dermatitis in a dairy herd caused by Pelodera strongyloides (Nematoda: Rhabditidae).
    J Vet Med B Infect Dis Vet Public Health, 52(4): 197-8. [Abstract] [Full-text]
17. Paediatric adverse drug reactions reported in Sweden from 1987 to 2001.
    Pharmacoepidemiol Drug Saf, 14(7): 493-9. [Abstract] [Full-text]
18. Pustulo-vesicular skin eruption in a child with probable Kawasaki disease.
    Eur J Pediatr. [Abstract] [Full-text]
19. Toxic epidermal necrolysis secondary to angioimmunoblastic T-cell lymphoma.
    Australas J Dermatol, 46(3): 187-91. [Abstract] [Full-text]
20. Fixed drug eruption with interferon-beta-1b.
    Australas J Dermatol, 46(3): 154-7. [Abstract] [Full-text]
21. Childhood vitiligo: a prospective hospital-based study.
    Australas J Dermatol, 46(3): 150-3. [Abstract] [Full-text]
22. Prevention of toxic epidermal necrolysis by regulatory T cells.
    Eur J Immunol, 35(6): 1722-30. [Abstract] [Full-text]
23. CXCR3 is required for migration to dermal inflammation by normal and in vivo activated T cells: differential requirements by CD4 and CD8 memory subsets.
    Eur J Immunol, 35(6): 1702-11. [Abstract] [Full-text]
24. Immune modulating nutrition support for a patient with severe toxic epidermal necrolysis.
    J Hum Nutr Diet, 18(4): 311-4. [Abstract] [Full-text]
25. A relapsing inflammatory syndrome and active human herpesvirus 8 infection.
    N Engl J Med, 353(2): 156-63. [Abstract] [Full-text]
26. IgE and Fc{epsilon}RI regulation.
    Ann N Y Acad Sci, 1050: 73-88. [Abstract] [Full-text]
27. Clinical characteristics and evolution of syphilis in 24 HIV+ individuals in Rio de Janeiro, Brazil.
    Rev Inst Med Trop Sao Paulo, 47(3): 153-7. [Abstract] [Full-text]
28. Effective therapy of childhood atopic dermatitis allays food allergy concerns.
    J Am Acad Dermatol, 53(2): S214-9. [Abstract] [Full-text]
29. Pneumococcal seroconversion after vaccination for children with atopic dermatitis treated with tacrolimus ointment.
    J Am Acad Dermatol, 53(2): S206-13. [Abstract] [Full-text]
30. Tacrolimus ointment is safe and effective in the treatment of atopic dermatitis: results in 8000 patients.
    J Am Acad Dermatol, 53(2): S195-205. [Abstract] [Full-text]
31. Efficacy and safety of tacrolimus ointment treatment for up to 4 years in patients with atopic dermatitis.
    J Am Acad Dermatol, 53(2): S186-94. [Abstract] [Full-text]
32. Tacrolimus ointment 0.03% shows efficacy and safety in pediatric and adult patients with mild to moderate atopic dermatitis.
    J Am Acad Dermatol, 53(2): S177-85. [Abstract] [Full-text]
33. The role of dendritic cell subtypes in the pathophysiology of atopic dermatitis.
    J Am Acad Dermatol, 53(2): S171-6. [Abstract] [Full-text]
34. The efficacy and safety of tacrolimus ointment: a clinical review.
    J Am Acad Dermatol, 53(2): S165-70. [Abstract] [Full-text]
35. Failure of omalizumab for treatment of severe adult atopic dermatitis.
    J Am Acad Dermatol, 53(2): 338-40. [Abstract] [Full-text]
36. Occupational contact dermatitis: etiology, prevalence, and resultant impairment/disability.
    J Am Acad Dermatol, 53(2): 303-13. [Abstract] [Full-text]
37. Rheumatoid arthritis: a review of the cutaneous manifestations.
    J Am Acad Dermatol, 53(2): 191-209; quiz 210-2. [Abstract] [Full-text]
38. Topical streptococcal preparation, OK-432, for atopic dermatitis.
    J Dermatolog Treat, 16(2): 117-20. [Abstract] [Full-text]
39. Atopic dermatitis -- topical therapy: do patients apply much too little?
    J Dermatolog Treat, 16(2): 95-101. [Abstract] [Full-text]
40. Efficacy of dietary hempseed oil in patients with atopic dermatitis.
    J Dermatolog Treat, 16(2): 87-94. [Abstract] [Full-text]
41. HgCl(2) challenge in Brown Norway rats lead to dermatitis instead of arthritis.
    Rheumatol Int. [Abstract] [Full-text]
42. Prevalence of claw lesions in Norwegian dairy cattle housed in tie stalls and free stalls.
    Prev Vet Med, 70(3): 191-209. [Abstract] [Full-text]
43. Novel C5a regulators in inflammatory disease.
    Expert Opin Investig Drugs, 14(7): 807-21. [Abstract] [Full-text]
44. Development and evaluation of Varicella zoster virus ELISA for oral fluid suitable for epidemiological studies.
    J Virol Methods, 128(1): 162-7. [Abstract] [Full-text]
45. Infective dermatitis and human T cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in childhood and adolescence.
    Clin Infect Dis, 41(4): 535-41. [Abstract] [Full-text]
46. Improved detection of allergen-specific T-cell responses in allergic contact dermatitis through the addition of 'cytokine cocktails'.
    Exp Dermatol, 14(8): 634-40. [Abstract] [Full-text]
47. MnSOD polymorphisms in sensitized patients with delayed-type hypersensitivity reactions to the chemical allergen para-phenylene diamine: a case-control study.
    Toxicology, 212(2): 148-54. [Abstract] [Full-text]
48. Cilomilast, tacrolimus and rapamycin modulate dendritic cell function in the elicitation phase of allergic contact dermatitis.
    Br J Dermatol, 153(1): 136-44. [Abstract] [Full-text]
49. Contact dermatitis to hair dyes in a Danish adult population: an interview-based study.
    Br J Dermatol, 153(1): 132-5. [Abstract] [Full-text]
50. Additive impairment of the barrier function by mechanical irritation, occlusion and sodium lauryl sulphate in vivo.
    Br J Dermatol, 153(1): 125-31. [Abstract] [Full-text]
51. A new endogenous retroviral sequence is expressed in skin of patients with psoriasis.
    Br J Dermatol, 153(1): 83-9. [Abstract] [Full-text]
52. Plaque psoriasis vs. atopic dermatitis and lichen planus: a comparison for lesional T-cell subsets, epidermal proliferation and differentiation.
    Br J Dermatol, 153(1): 72-8. [Abstract] [Full-text]
53. Porcine dermatitis and nephropathy syndrome (PDNS) is associated with a systemic cytokine expression profile indicative of proinflammation and a Th1 bias.
    Vet Immunol Immunopathol, 107(3): 303-13. [Abstract] [Full-text]
54. Pimecrolimus in dermatology: atopic dermatitis and beyond.
    Int J Clin Pract, 59(8): 969-74. [Abstract] [Full-text]
55. The management of skin reactions in cancer patients receiving epidermal growth factor receptor targeted therapies.
    J Dtsch Dermatol Ges, 3(8): 599-606. [Abstract] [Full-text]
56. Acrylates induced rhinitis and contact dermatitis.
    Contact Dermatitis, 53(2): 114. [Abstract] [Full-text]
57. Survey of sulfur-containing rubber accelerator levels in latex and nitrile exam gloves.
    Contact Dermatitis, 53(2): 107-13. [Abstract] [Full-text]
58. Gene transcripts as potential diagnostic markers for allergic contact dermatitis.
    Contact Dermatitis, 53(2): 100-6. [Abstract] [Full-text]
59. Contact vitiligo following a strong patch test reaction to triglycidyl-p-aminophenol in an aircraft industry worker: case report and review of the literature.
    Contact Dermatitis, 53(2): 89-92. [Abstract] [Full-text]
60. Evolution of clinical pattern of parthenium dermatitis: a study of 74 cases.
    Contact Dermatitis, 53(2): 84-8. [Abstract] [Full-text]
61. Patch testing with p-toluene diamine preparations of different ages.
    Contact Dermatitis, 53(2): 75-9. [Abstract] [Full-text]
62. Detection of contact hypersensitivity to corticosteroids in allergic contact dermatitis patients who do not respond to topical corticosteroids.
    Contact Dermatitis, 53(2): 67-70. [Abstract] [Full-text]
63. Myelodysplastic syndrome associated with multiple autoimmune disorders.
    Clin Rheumatol, 24(4): 428-30. [Abstract] [Full-text]
64. Reactive nitrogen species formation in eosinophils and imbalance in nitric oxide metabolism are involved in atopic dermatitis-like skin lesions in NC/Nga mice.
    Free Radic Res, 39(7): 719-27. [Abstract] [Full-text]
65. Stable incidence of atopic dermatitis among children in Denmark during the 1990s.
    Acta Derm Venereol, 85(3): 244-7. [Abstract] [Full-text]
66. Thymus is enlarged in children with current atopic dermatitis. A cross-sectional study.
    Acta Derm Venereol, 85(3): 240-3. [Abstract] [Full-text]
67. Density of Demodex folliculorum in perioral dermatitis.
    Acta Derm Venereol, 85(3): 211-5. [Abstract] [Full-text]
68. Fruit acids do not enhance sodium lauryl sulphate-induced cumulative irritant contact dermatitis in vivo.
    Acta Derm Venereol, 85(3): 206-10. [Abstract] [Full-text]
69. Immunological profile of peripheral blood lymphocytes and monocytes/macrophages in Kawasaki disease.
    Clin Exp Immunol, 141(3): 381-7. [Abstract] [Full-text]
70. Paraneoplastic syndrome and intrathoracic Castleman disease.
    Pediatr Blood Cancer. [Abstract] [Full-text]
71. Interleukin-4 and interleukin-13 enhance CCL26 production in a human keratinocyte cell line, HaCaT cells.
    Clin Exp Immunol, 141(3): 459-66. [Abstract] [Full-text]
72. Quantum mechanical structure-activity relationship analyses for skin sensitization.
    J Chem Inf Model, 45(4): 924-9. [Abstract] [Full-text]
73. Infestation of Werneckiella equi on Icelandic horses, characteristics of predilection sites and lice dermatitis.
    Parasitol Res, 96(6): 398-401. [Abstract] [Full-text]
74. Family-based association analysis implicates IL-4 in susceptibility to Kawasaki disease.
    Genes Immun, 6(5): 438-44. [Abstract] [Full-text]
75. A phase II, open-label study of gefitinib (IRESSA) in patients with locally advanced, metastatic, or relapsed renal-cell carcinoma.
    Cancer Chemother Pharmacol. [Abstract] [Full-text]
76. Cutaneous adverse effects with HER1/EGFR-targeted agents: is there a silver lining?
    J Clin Oncol, 23(22): 5235-46. [Abstract] [Full-text]
77. Cyclobutane pyrimidine dimer formation is a molecular trigger for solar-simulated ultraviolet radiation-induced suppression of memory immunity in humans.
    Photochem Photobiol Sci, 4(8): 577-82. [Abstract] [Full-text]

© 2004-2008 Skin Rashes Research Today. All Rights Reserved.